XORTX Share Price

XORTX Share Price

NASDAQ: XRTX | Others
$0.82
+$0.82 (--%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

XORTX Stock Performance

Open
$0.88
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.84 - $0.88
Year Range
$0.36 - $3.57
Volume
4,829
Average Traded
$0.85

XORTX Share Price Chart

Line chart of the XORTX price trend over the selected period. The price rose overall, ranging from 0.84 to 0.88, ending at 0.84.
$0.84$0.88
L
Show Current Price
H

XORTX Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

XORTX Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$7.72-$2.16-$3.31-$2.66
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A72.02%-53.24%19.64%

XORTX Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.421.421.41.48
Current Assets1.262.684.0710.9
Total Assets2.684.095.4712.37
Non Current Liabilities0.00.00.03.87
Current Liabilities0.60.760.831.51
Total Liabilities0.60.760.835.38
Shareholders' Equity2.083.344.647.0

XORTX Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-2.77-3.68-6.58-8.17
Investing-0.29-0.04-0.05-0.05
Financing1.432.78-0.363.91

Corporate Actions

Split
Ex-date: 06 Apr 2026

Split
Ex-date: 14 Nov 2023

About XORTX

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

XORTX Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.02
$0.84
-20.75%
Oct 2026
$1.75
$1.06
-38.01%
Sep 2026
$2.27
$1.71
-16.59%
Aug 2026
$2.12
$2.05
-1.68%
Jul 2026
$2.16
$2.08
-6.08%
Jun 2026
$2.22
$2.22
-2.42%
May 2026
$2.70
$2.27
-21.28%
Apr 2026
$0.46
$2.89
+658.53%
Mar 2026
$0.39
$0.38
-6.85%
Feb 2026
$0.52
$0.41
-19.80%
Jan 2026
$0.59
$0.51
-17.07%
Dec 2025
$0.63
$0.61
-6.11%

XORTX Share Price FAQs